Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: A 5-year blinded prospective follow-up study

Archives of Dermatology

Volumn 138, Issue 3, 2002, Pages 353-357

  Sigurgeirsson, Bárour ^a   Ólafsson, Jón H ^a   Steinsson, Jón P ^b   Paul, Carle ^c   Billstein, Stephan ^c   Glyn V Evans, E ^d  

^a UNIVERSITY OF ICELAND   (Iceland)

^b Mulhouse Hospital   (France)

^c NOVARTIS PHARMA AG   (Switzerland)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE; TERBINAFINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ONYCHOMYCOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM;

ADULT; AGED; ANTIFUNGAL AGENTS; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; FOOT DERMATOSES; HUMANS; ITRACONAZOLE; LONGITUDINAL STUDIES; MIDDLE AGED; NAPHTHALENES; ONYCHOMYCOSIS; PROSPECTIVE STUDIES; RECURRENCE; RETREATMENT; TINEA; TREATMENT OUTCOME; TRICHOPHYTON;

EID: 0036120887     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Prevalence of dermatophyte onychomycosis in the United Kingdom: Results of an omnibus survey
2. The prevalence of onychomycosis in Finland
3. Prevalence of dermatophyte onychomycosis in Spain: A cross-sectional study
4. Onychomycosis in icelandic swimmers
5. A higher prevalence of onychomycosis in psoriatics compared with non-psoriatics: A multicentre study
6. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: A multicentre survey
7. Effect of onychomycosis on quality of life
8. Crinkly toenails: Toenail onychomycosis can cause serious problems
9. Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis
10. LION Study: Efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis: Lamisil vs itraconazole in onychomycosis
11. How often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published data
12. Carry-forward analysis
13. Short-term treatment of dermatophyte onychomycosis with terbinafine
14. Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy
15. Antifungal pulse therapy for onyohomycosis: A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole
16. Treatment of toenail onychomycosis: A randomized, double-blind study with terbinafine and griseofulvin
17. Oral antifungal agents for onychomycosis
18. A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis
19. Randomised double blind comparison of terbinafine and itraconazote for treatment of toenail tinea infection
20. Long-term outgomes in the treatment of toenail onychomycosis
21. Long-term results of patients with onychomycosis treated with itraconazole
22. Long-term follow up of patients with toenail onychomycosis after treatment with terbinafine
23. Impact of onychomycosis on quality of life
24. A double-blind comparison of levels of terbinafine and itraconazole in plasma, skin, sebum, hair and nails during and after oral medication